Institution statistics

ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS - France 

Ranking results:

Past rankings:
2018
Criterium:Position:
Overall Score:300-400
Total Project Funding per Partner:200-300
Total Number of Projects:100-200
Networking Rank (Reputation):> 1000
2017
Criterium:Position:
Overall Score:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:200-300
Networking Rank (Reputation):100-200
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:400-500
Total Number of Projects:400-500
Networking Rank (Reputation):300-400
Partner Constancy:300-400
Project Leadership Index:500-600
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):900-1000
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding:100-200
Total Project Funding per Partner:200-300
Total Number of Projects:64
Partner Constancy:50
Project Leadership Index:69
Diversity Index:41
2012
Criterium:Position:
Overall Score:400-500
Total Project Funding:100-200
Total Project Funding per Partner:100-200
Total Number of Projects:61
Networking Rank (Reputation):200-300
Networking Rank (Reputation):200-300
Partner Constancy:43
Project Leadership Index:66
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:200-300
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
Partner Constancy:200-300
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:700-800
Total Project Funding:200-300
Total Project Funding per Partner:400-500
Total Number of Projects:600-700
Networking Rank (Reputation):400-500
Partner Constancy:300-400
Project Leadership Index:300-400
Diversity Index:> 1000
2009
Criterium:Position:
Overall Score:300-400
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):300-400
Partner Constancy:> 1000
Project Leadership Index:300-400
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:600-700
Total Project Funding:400-500
Total Project Funding per Partner:300-400
Total Number of Projects:300-400
Networking Rank (Reputation):400-500
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:400-500
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding:200-300
Total Project Funding per Partner:300-400
Total Number of Projects:800-900
Networking Rank (Reputation):500-600
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
Ranking timeline:

European project participation (2000-01-01 - 2019-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 156
As coordinator: 9
As participant: 147
Sole participant: 0
Coordinator / Participant Ratio: 0.06*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 102.444.206 3.969.568 7
2018 0 134.922.280 5.300.401 14
2017 6.189.570 92.235.116 4.033.568 1 11
2016 0 11.598.619 772.835 3
2015 0 42.287.851 2.200.779 8
2014 4.500.962 5.206.530 1.468.803 1 3
2013 0 88.682.255 4.213.364 10
2012 5.900.000 62.332.099 4.348.146 1 10
2011 0 78.648.314 2.043.179 11
2010 5.983.478 49.989.501 2.785.675 1 6
2009 2.989.154 24.922.118 1.941.656 1 6
2008 0 26.208.018 2.081.005 8
2007 0 21.207.358 763.160 2
2006 0 57.771.199 3.541.212 7
2005 0 2.722.199 117.109 3
2004 0 13.004.284 634.946 4
2003 1.399.714 7.493.889 1.013.486 1 8
2002 4.225.544 14.120.850 1.783.614 3 10
2001 0 11.200.747 1.710.201 7
2000 0 13.704.602 1.535.402 9
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE49
UNIVERSITY COLLEGE LONDON37
KAROLINSKA INSTITUTE21
STICHTING KATHOLIEKE UNIVERSITEIT20
KATHOLIEKE UNIVERSITEIT LEUVEN19
UNIVERSITY OF NEWCASTLE UPON TYNE19
CHARITE UNIVERSITAETSMEDIZIN BERLIN17
KING'S COLLEGE LONDON15
UNIVERSITAET ULM15
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM13
INSERM TRANSFERT13
UNIVERSITAIR MEDISCH CENTRUM UTRECHT13
SERVICIO MADRILENO DE SALUD12
COMMISSARIAT A L'ENERGIE ATOMIQUE11
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK10
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON10
REGION HOVEDSTADEN10
THE UNIVERSITY OF LIVERPOOL10
UNIVERSITA DEGLI STUDI DI PADOVA10
ACADEMISCH ZIEKENHUIS GRONINGEN9
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE9
ISTITUTO SUPERIORE DI SANITA9
MEDIZINISCHE HOCHSCHULE HANNOVER9
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD9
UNIVERSITA DEGLI STUDI DI TORINO9
UNIVERSITY OF DUNDEE9
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM8
CENTRE HOSPITALIER UNIVERSITAIRE DE MONTPELLIER8
CENTRE HOSPITALIER UNIVERSITAIRE DE NANTES8
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE8
INSTITUT PASTEUR8
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE8
UNIVERSITA CATTOLICA DEL SACRO CUORE8
UNIVERSITE DE GENEVE8
UPPSALA UNIVERSITET8
ASSOCIATION POUR LA RECHERCHE SUR LES TRANSPLANTATIONS MEDULLAIRES7
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE7
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER7
FUNDACIO PRIVADA CLINIC PER A LA RECERCA BIOMEDICA7
HEINRICHHEINEUNIVERSITAET DUESSELDORF7
INSTITUT CATALA DE LA SALUT7
LUNDS UNIVERSITET7
OSPEDALE PEDIATRICO BAMBINO GESU7
UNIVERSITAETSKLINIKUM FREIBURG7
UNIVERSITY OF COPENHAGEN7
UNIVERSITY OF GLASGOW7
WESTFAELISCHE WILHELMSUNIVERSITAET MUENSTER7
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM6
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE6
EBERHARD KARLS UNIVERSITAET TUEBINGEN6
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O6
GENETHON6
HELSINKI UNIVERSITY CENTRAL HOSPITAL6
HOSPICES CIVILS DE LYON6
MEDIZINISCHE UNIVERSITAET WIEN6
NOVARTIS PHARMA6
STATENS SERUM INSTITUT6
THE UNIVERSITY OF EDINBURGH6
THE UNIVERSITY OF NOTTINGHAM6
THE UNIVERSITY OF SHEFFIELD6
UNIVERSITA DEGLI STUDI DI PERUGIA6
UNIVERSITAETSKLINIKUM HEIDELBERG6
UNIVERSITE DE LIEGE6
UNIVERSITE LIBRE DE BRUXELLES6
UNIVERSITY OF MANCHESTER6
FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON INSTITUT DE RECERCA5
HLA ET MEDECINE5
ISTITUTO ORTOPEDICO RIZZOLI5
JOHANN WOLFGANG GOETHEUNIVERSITATFRANKFURT AM MAIN5
LEIDEN UNIVERSITY5
LEIDEN UNIVERSITY MEDICAL CENTER5
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN5
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN5
MEDICAL RESEARCH COUNCIL5
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS5
THE UNIVERSITY OF MILANO5
UNIVERSIDAD COMPLUTENSE DE MADRID5
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA5
UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA5
UNIVERSITAET BERN5
UNIVERSITAET LEIPZIG5
UNIVERSITAET ZUERICH5
UNIVERSITAETSKLINIKUM AACHEN5
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS5
UNIVERSITE DE PARIS VII DENIS DIDEROT5
UNIVERSITE PARIS DESCARTES5
UNIVERSITEIT ANTWERPEN5
UNIVERSITY OF BIRMINGHAM5
UNIVERSITY OF BOLOGNA5
UNIVERSITY OF BRISTOL5
UNIVERSITY OF LEEDS5
UNIVERSITY OF TORINO5
UNIVERSITY OF WALES CARDIFF5
VIB5
ACADEMISCH ZIEKENHUIS LEIDEN4
CENTRO S GIOVANNI DI DIO FATEBENEFRATELLI ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO4
CONSIGLIO NAZIONALE DELLE RICERCHE4
DEUTSCHES KREBSFORSCHUNGSZENTRUM4
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH4
ELI LILLY AND COMPANY LIMITED4
Constancy:

Total number of partners:2654

Partner loyalty:
Frequent Partner: (> 2 projects): 1126
Rare Partner: 1528

Frequent / Rare Partner Ratio: 0.74

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES91
RTD HORIZONTAL TOPICS43
SOCIAL AND ECONOMIC CONCERNS31
PROTECTING MAN AND HIS ENVIRON12
INDUSTRY AND TECHNOLOGY8
AGRICULTURE AND MARINE RESOURC1

Project overview:

Start dateProjectacronymrolefundingpartners
2019-09-01The First Responder (FR) of the Future: a Next Generation Integrated Toolkit (NGIT) for Collaborative Response, increasing protection and augmenting operational capacity INGENIOUSparticipant8.616.11123
2019-03-01CARdiomyopathy in type 2 DIAbetes mellitus CARDIATEAMparticipant6.700.00021
2019-02-01Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease TransBioLineparticipant13.999.99827
2019-01-01EURopean wide Innovative Procurement of Health Innovation EURIPHIparticipant1.997.34127
2019-01-01ARCHITECTURE AND TOOLS FOR THE QUERY OF ANTIBODY AND T-CELL RECEPTOR SEQUENCING DATA REPOSITORIES FOR ENABLING IMPROVED PERSONALIZED MEDICINE AND IMMUNOTHERAPY iReceptor Plusparticipant7.856.92520
2019-01-01European Joint Programme on Rare Diseases EJP RDparticipant55.073.83188
2019-01-01NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients NECESSITYparticipant8.200.00025
2018-11-01COllaborative Consortium for the early detection of LIver CANcer COCLICANparticipant450.8008
2018-06-01Network Of practitioners For Emergency medicAl systems and cRitical care NO FEARparticipant3.495.95818
2018-06-01Autism Innovative Medicine Studies – 2 – Trials AIMS-2-TRIALSparticipant54.999.99948
2018-05-01Immunome project consortium for AutoInflammatory Disorders ImmunAIDparticipant15.835.85124
2018-04-01Improving the care of patients suffering from acute or chronic pain IMI-PainCareparticipant11.225.27140
2018-01-01The EUropean TRAnsplantation and INnovation (EU-TRAIN) consortium for improving diagnosis and risk stratification in kidney transplant patients EU-TRAINparticipant6.641.54612
2018-01-01Improved Methods and Actionable Tools for Enhancing Health Technology Assessment IMPACT HTAparticipant4.593.30615
2018-01-01Optimizing response to Li treatment through personalized evaluation of individuals with bipolar I disorder: the R-LiNK initiative R-LiNKparticipant7.702.53221
2018-01-01Adeno-Associated Virus Vector-Mediated Liver Gene Therapy for Crigler-Najjar Syndrome CureCNparticipant6.249.10411
2018-01-01Infradev - European Paediatric Translational Research Infrastructure ID-EPTRIparticipant3.000.00026
2018-01-01How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model RECAGEparticipant2.824.03819
2018-01-01Stem-cell based gene therapy for recombination deficient SCID (RECOMB) RECOMBparticipant5.990.46017
2018-01-01Personalised maxillofacial bone regeneration MAXIBONEparticipant5.949.66512
2018-01-01Immune Signatures for Therapy Stratification in Major Mood Disorders MOODSTRATIFICATIONparticipant5.963.75012
2017-12-01Repurposing of carbamazepine for treatment of skeletal dysplasia MCDS-Therapyparticipant5.697.39110
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88154
2017-09-01An INtegrated next generation PREParedness programme for improving effective inter-organisational response capacity in complex environments of disasters and causes of crises IN-PREPparticipant7.999.55620
2017-09-01Targeting the metabolism-immune system connections in Cancer META-CANparticipant3.831.95820
2017-06-01PAN EBOLA VACCINE INNOVATIVE APPROACH – Sofia ref.: 116088 PEVIAcoordinator6.189.57014
2017-01-01REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy RESPINEparticipant5.555.83615
2017-01-01Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection HIVACARparticipant6.685.11115
2017-01-01HARMONIzation and integrative analysis of regional, national and international Cohorts on primary Sjögren’s Syndrome (pSS) towards improved stratification, treatment and health policy making HarmonicSSparticipant9.998.75039
2017-01-01Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026 HARMONYparticipant20.200.00053
2017-01-01SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS LIVERHOPEparticipant5.998.80018
2017-01-01Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF) ALIVERparticipant6.478.73811
2017-01-013-O-sulfated heparan sulfate translocation in altered membrane biology: A new strategy for early population screening and halting Alzheimer’s neurodegeneration ArrestADparticipant3.991.0968
2016-10-01Expanding and extending gene therapy of monogenic diseases of the haematopoietic system GENE FOR CUREparticipant2.445.2682
2016-02-01Decision Support and Information Management System for Breast Cancer DESIREEparticipant3.340.72012
2016-01-01Imaging the Force of Cancer FORCEparticipant5.812.63116
2015-11-01EVA - patient ventilation beyond limits EVAparticipant1.890.0005
2015-10-01Innovative training network: Immunoprofile-directed stratification of patients with the autoimmune disorder thrombotic thrombocytopenic purpura PROFILEparticipant1.464.3989
2015-09-01REgenerative Stem cell therapy for STroke in Europe RESSTOREparticipant6.338.25931
2015-05-01I-MOVE+ Integrated Monitoring of Vaccines Effects in Europe: a platform to measure and compare effectiveness and impact of influenza and pneumococcal vaccines and vaccination strategies in the elderly I-MOVE-plusparticipant7.482.72925
2015-05-01A EUropean study on effectiveness and sustainability of current Cardiac Rehabilitation programmes in the Elderly EU-CaREparticipant5.593.04910
2015-05-01Application of omics-based strategies for improved diagnosis and treatment of endocrine hypertension ENSAT-HTparticipant7.607.33713
2015-05-01Clinical evaluation of carbons of controlled porosity as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty liver disease. CARBALIVEparticipant5.913.08014
2015-01-01Clinical trial of autologous adipose-derived mesenchymal stromal cells (ASC) in the treatment of mild to moderate osteoarthritis ADIPOA2participant5.999.00018
2014-11-01Prevention and Management of High Threat Pathogen Incidents in Transport Hubs PANDHUBparticipant3.142.0046
2014-04-01Mimimally invasive retrograde targeting of aCAR lentiviral vector to non-human primate motor neurons RTLVNHPparticipant149.5262
2014-01-01Tissue engineering of the right heart outflow tract by a biofunctionalized bioresorbable polymeric valved tube TEH-TUBEcoordinator4.500.9627
2014-01-01Demonstrating Minicare, a miniaturized biophotonics platform for fast and lab-equivalent Point-of-Care diagnostics Lab2Goparticipant1.915.00010
2013-12-01A Phase Ib/II study of MEK1/2 inhibitor PD-0325901 with cMET inhibitor PF-02341066 in KRASMT and KRASWT (with aberrant c-MET) Colorectal Cancer Patients MERCURICparticipant5.999.99513
2013-10-01A drug strategy targeting stabilised mutant p53 to fight metastatic platinum-resistant ovarian cancer GANNET53participant5.994.07218

overview shows latest 50 from 156 projects (2000-01-01 - 2019-12-31)
A full list of projects can be found here:

Alias institution names:
  • ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum